Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in High Risk Cardiac Surgery
NCT00994825Phase 4Completed
- Sponsor
- Vita-Salute San Raffaele University
- Start
- Nov 2009
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of levosimendan in low cardiac output syndrome (LCOS), sponsored by Vita-Salute San Raffaele University. Started Nov 2009; status: completed.
02
Drugs
levosimendan
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on NCT00994825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00994825.